Risultati della ricerca - Günter Fingerle‐Rowson

Raffina i risultati
  1. 1
    A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies

    A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies di Kensei Tobinai, Christian Klein, Naoko Oya, Günter Fingerle‐Rowson

    Pubblicazione 2016
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy

    Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy di Günter Fingerle‐Rowson, Matthias Angstwurm, R Andreesen, H.W.L. Ziegler-Heitbrock

    Pubblicazione 1998
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response

    Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response di Robert A. Mitchell, Hong Liao, Jason Chesney, Günter Fingerle‐Rowson, John A. Baugh, John R. David, Richard Bucala

    Pubblicazione 2001
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression

    Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression di Ramona Schulz, Natalia Marchenko, Lena Holembowski, Günter Fingerle‐Rowson, Marina Pešić, Lars Zender, Matthias Dobbelstein, Ute M. Moll

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo

    Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo di Günter Fingerle‐Rowson, Peter D. Koch, Rachel Bikoff, Xinchun Lin, Christine N. Metz, Firdaus S. Dhabhar, Andreas Meinhardt, Richard Bucala

    Pubblicazione 2003
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Macrophage Migration Inhibitory Factor and CD74 Regulate Macrophage Chemotactic Responses via MAPK and Rho GTPase

    Macrophage Migration Inhibitory Factor and CD74 Regulate Macrophage Chemotactic Responses via MAPK and Rho GTPase di Huapeng Fan, Pam Hall, Leilani L. Santos, Julia L. Gregory, Günter Fingerle‐Rowson, Richard Bucala, Eric F. Morand, Michael J. Hickey

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Macrophage Migration Inhibitory Factor Inhibits the Antiinflammatory Effects of Glucocorticoids via Glucocorticoid‐Induced Leucine Zipper

    Macrophage Migration Inhibitory Factor Inhibits the Antiinflammatory Effects of Glucocorticoids via Glucocorticoid‐Induced Leucine Zipper di Huapeng Fan, Wenping Kao, Yuan Yang, Ran Gu, James Harris, Günter Fingerle‐Rowson, Richard Bucala, Devi Ngo, Élaine Beaulieu, Eric F. Morand

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting

    The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting di Günter Fingerle‐Rowson, Oleksi Petrenko, Christine N. Metz, Thomas G. Forsthuber, Robert A. Mitchell, Ralf Huss, Ute M. Moll, Werner Müller, Richard Bucala

    Pubblicazione 2003
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice

    Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice di Leilani L. Santos, Huapeng Fan, Pam Hall, Devi Ngo, Charles R. Mackay, Günter Fingerle-Rowson, Richard Bucala, Michael J. Hickey, Eric F. Morand

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis

    Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis di Lara J. Herrero, Michelle Nelson, Anon Srikiatkhachorn, Ran Gu, Surapee Anantapreecha, Günter Fingerle‐Rowson, Richard Bucala, Eric F. Morand, Leilani L. Santos, Suresh Mahalingam

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury

    The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury di Dake Qi, Kwame Atsina, Lintao Qu, Xiaoyue Hu, Xiaohong Wu, Bin Xu, Marta Piecychna, Lin Leng, Günter Fingerle‐Rowson, Jiasheng Zhang, Richard Bucala, Lawrence H. Young

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis

    Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis di Ran Gu, Leilani L. Santos, Devi Ngo, Huapeng Fan, Preetinder P. Singh, Günter Fingerle‐Rowson, Richard Bucala, Jiake Xu, Julian M.W. Quinn, Eric F. Morand

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study

    Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study di Valentin Goede, Kirsten Fischer, Anja Engelke, Rudolf Schlag, Stéphane Leprêtre, Luis Felipe Casado Montero, Marco Montillo, Chris Fegan, Elina Asikanius, K. Humphrey, Günter Fingerle‐Rowson, Michael Hallek

    Pubblicazione 2015
    Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  14. 14
    Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions

    Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions di Ciara L. Freeman, Franck Morschhauser, Laurie H. Sehn, Mark Dixon, Richard Houghton, Thierry Lamy, Günter Fingerle‐Rowson, Elisabeth Wassner-Fritsch, John G. Gribben, Michael Hallek, Gilles Salles, Guillaume Cartron

    Pubblicazione 2015
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  15. 15
    MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model

    MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model di Pathricia V. Tilstam, Wibke Schulte, Thomas Holowka, Bong‐Sung Kim, Jessica Nouws, Maor Sauler, Marta Piecychna, Georgios Pantouris, Elias Lolis, Lin Leng, Jürgen Bernhagen, Günter Fingerle‐Rowson, Richard Bucala

    Pubblicazione 2021
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer

    Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer di Leona Mawhinney, Michelle E. Armstrong, Ciaran O’Reilly, Richard Bucala, Lin Leng, Günter Fingerle‐Rowson, Darren Fayne, Michael P. Keane, Aisling Tynan, Lewena Maher, Gordon Cooke, David G. Lloyd, Helen Conroy, Seamas C. Donnelly

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study

    Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study di Christopher R. Bolen, Magdalena Klánová, Marek Trněný, Laurie H. Sehn, Jie He, Jing Tong, Joseph N. Paulson, Eugene Kim, Umberto Vitolo, Alice Di Rocco, Günter Fingerle‐Rowson, Tina Nielsen, Georg Lenz, Mikkel Z. Oestergaard

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Macrophage Migration Inhibitory Factor Enzymatic Activity, Lung Inflammation, and Cystic Fibrosis

    Macrophage Migration Inhibitory Factor Enzymatic Activity, Lung Inflammation, and Cystic Fibrosis di Huzaifa Adamali, Michelle E. Armstrong, Anne Marie McLaughlin, Gordon Cooke, Edward F. McKone, Christine Costello, Charles G. Gallagher, Lin Leng, John A. Baugh, Günter Fingerle‐Rowson, Richard Bucala, Paul McLoughlin, Seamas C. Donnelly

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

    Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Rando... di Sebastian Böttcher, Matthias Ritgen, Kirsten Fischer, Stephan Stilgenbauer, Raymonde M. Busch, Günter Fingerle‐Rowson, Anna Maria Fink, Andreas Bühler, Thorsten Zenz, Michael Wenger, Myriam Mendila, Clemens‐Martin Wendtner, Barbara Eichhorst, Hartmut Döhner, Michael Hallek, Michael Kneba

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL

    A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL di Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, Günter Fingerle‐Rowson, Jasmin Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J. M. van Dongen, Matthias Ritgen, Sebastian Böttcher, Anton W. Langerak, Michael Kneba, Michael Hallek

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: